Table 3 Different drug regimens and the numbers of studies/case reports with each drug regimens
From: Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
Dose and regimen as given in the article | Randomized control trials | Case reports and case series | Cohort study |
|---|---|---|---|
Oral co-trimoxazole 960Â mg (Trimethoprim/Sulfamethoxazole) once daily | 0 | 04 | 0 |
Oral co-trimoxazole 960Â mg (Trimethoprim/Sulfamethoxazole) twice daily | 02 | 10 | 0 |
Oral co-trimoxazole 1920Â mg (Trimethoprim/Sulfamethoxazole) twice daily | 02 | 10 | 1 |
Oral co- trimoxazole (10mg TMP + 50mg SMX/kg/day in 2 divided doses) | 02 | 0 | 0 |
Oral co-trimoxazole 240/1200Â mg (Trimethoprim/Sulfamethoxazole) orally twice a day | 0 | 02 | 0 |
Oral co-trimoxazole 10Â mg/kg (Trimethoprim/Sulfamethoxazole) | 0 | 01 | 0 |